Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study

ConclusionLetermovir was generally well tolerated, and the data support its use for the prevention of CMV disease/infection in adult Japanese KTRs.Trial registrationClinicalTrials.gov NCT04129398.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research